Results 191 to 200 of about 621,376 (215)

GPC2-CAR T cells tuned for low antigen density mediate potent activity against neuroblastoma without toxicity

Cancer Cell, 2022
Kevin R. Parker, Anya Alag, Crystal Mackall   +2 more
exaly  

83D4; antigen: Tn

Hybridoma, 1997
openaire   +1 more source

Prostate-specific antigen: Current status†

Ca-A Cancer Journal for Clinicians, 1999
Michael K Brawer, M K Brawer
exaly  

Prostate-specific antigen and premalignant change: Implications for early detection

Ca-A Cancer Journal for Clinicians, 1989
Michael K Brawer, P H Lange
exaly  

How to use prostate-specific antigen in the early detection orscreening for prostatic carcinoma

Ca-A Cancer Journal for Clinicians, 1995
Michael K Brawer, M K Brawer
exaly  

A review of cancer immunotherapy toxicity

Ca-A Cancer Journal for Clinicians, 2020
Lucy Boyce Kennedy
exaly  

The use of cancer registry data to study preoperative carcinoembryonic antigen level as an indicator of survival in colorectal cancer

Ca-A Cancer Journal for Clinicians, 1989
Joan Chmiel, A Fremgen
exaly  

Cathepsin S Regulates Antigen Processing and T Cell Activity in Non-Hodgkin Lymphoma

Cancer Cell, 2020
Stéphanie Sungalee, George Coukos, Pedro Farinha   +2 more
exaly  

Regulation of antigen presentation by Mycobacterium tuberculosis: a role for Toll-like receptors

Nature Reviews Microbiology, 2010
W Henry Boom, Clifford V Harding
exaly  

The ins and outs of MHC class II-mediated antigen processing and presentation

Nature Reviews Immunology, 2015
Paul A Roche
exaly